Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
显示2019年之前的680次新闻发布
-
AstraZeneca to divest Myalept to Aegerion
-
AstraZeneca PLC third quarter and nine months results 2014
-
MedImmune strengthens immuno-oncology capabilities with acquisition of Definiens
-
AstraZeneca, Pharmacyclics and Janssen partner on immuno-oncology combination trials with IMBRUVICA® for haematological cancers
-
AstraZeneca and Pharmacyclics enter clinical trial collaborations in oncology
-
AstraZeneca completes strategic transaction with Almirall in respiratory disease
-
US FDA approves once-daily XIGDUO™ XR tablets for adults with Type 2 Diabetes
-
AstraZeneca launches Healthy Heart Africa programme to address hypertension in Africa
-
Lynparza™ (olaparib) receives positive CHMP opinion in the EU for the maintenance treatment of BRCA-mutated platinum sensitive relapsed ovarian cancer
-
AstraZeneca strengthens partnership with the University of Cambridge
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
导演全球媒体关系(肿瘤学)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106